Avoiding the word “cancer” when talking to patients about their low-grade, localized prostate cancer may convince more men—at least 100 000 each year—to consider delaying immediate treatment in favor of active surveillance, recommended an independent panel convened in December by the National Institutes of Health.
Although the experts' state-of-the-science statement did not suggest a less anxiety-provoking term, it strongly called for better ways for physicians to counsel patients about active monitoring, which is sometimes presented to patients as “doing nothing.” Primary care physicians in particular “could set the stage for surveillance to be an alternative [to curative treatment] if the patient chooses to be screened” for prostate cancer, said Patricia Ganz, MD, the panel chair and director of the Division of Cancer Prevention and Control Research at the University of California in Los Angeles.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.